1043903-19-0

Basic information

• Product Name: [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid
• Synonyms: [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid
• CAS NO: 1043903-19-0
• Molecular Formula: C7H5N3O2
• Molecular Weight: 163
• EINECS: -0
• Mol File: 1043903-19-0.mol

Chemical Properties

• Appearance: /
• Density: 1.58
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: Aqueous Base (Slightly), DMSO (Slightly)
• PKA: 0.27±0.41(Predicted)
• CAS DataBase Reference: [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid(1043903-19-0)
• EPA Substance Registry System: [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid(1043903-19-0)

Safety Data

• Hazardous Substances Data: 1043903-19-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Drug Development:
[1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid serves as a key intermediate in the synthesis of pharmaceutical drugs due to its potential biological activities. Its unique structure allows for the development of new therapeutic agents with applications in various medical fields.
Used in Organic Synthesis:
As a building block in organic synthesis, [1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid is utilized for the creation of complex organic molecules, contributing to the advancement of chemical research and the discovery of novel compounds with specific properties.
Used in Fine Chemical Production:
[1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid's versatility as an intermediate makes [1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid instrumental in the production of various fine chemicals, which are essential in industries such as pharmaceuticals, agrochemicals, and materials science.
Used in Medicinal Chemistry and Drug Discovery:
The structural characteristics of [1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid make it a promising candidate for the development of innovative therapeutic agents. Its potential applications in medicinal chemistry and drug discovery include the design and synthesis of new drugs targeting specific diseases and conditions.

InChI:InChI=1S/C7H5N3O2/c11-7(12)5-1-2-6-8-4-9-10(6)3-5/h1-4H,(H,11,12)

Upstream product

• 1072-97-5 5-bromo-2-pyridylamine 
• 138888-98-9 N’-(5-bromopyridin-2-yl)-N,N-dimethylformimidamide 
• 356560-80-0 6-bromo[1,2,4]triazolo[1,5-a]pyridine 

Downstream Products

• 1454284-56-0 [1,2,4]triazolo[1.5-a]pyridine-6-carboxylic acid 4-benzenesulfonylbenzylamide 

Relevant articles and documents

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES

Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.

AMIDO-BENZYL SULFONE AND SULFONAMIDE DERIVATIVES

Disclosed are certain amido-benzyl sulfone and sulfonamide compounds, pharmaceutical compositions comprising such compounds, land methods of treatment using such compounds.

AMIDO-BENZYL SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat

ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES

The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,